Prana Capital Management LP Has $4.29 Million Stock Position in Humana Inc. (NYSE:HUM)

Prana Capital Management LP lessened its position in Humana Inc. (NYSE:HUM) by 43.8% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,555 shares of the insurance provider’s stock after selling 10,578 shares during the period. Prana Capital Management LP’s holdings in Humana were worth $4,293,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. IHT Wealth Management LLC boosted its position in shares of Humana by 38.2% during the 3rd quarter. IHT Wealth Management LLC now owns 1,082 shares of the insurance provider’s stock valued at $334,000 after purchasing an additional 299 shares in the last quarter. Investment Management Corp of Ontario boosted its holdings in Humana by 42.9% in the third quarter. Investment Management Corp of Ontario now owns 3,996 shares of the insurance provider’s stock worth $1,266,000 after acquiring an additional 1,200 shares in the last quarter. Janus Henderson Group PLC boosted its holdings in Humana by 6.3% in the third quarter. Janus Henderson Group PLC now owns 903,448 shares of the insurance provider’s stock worth $286,138,000 after acquiring an additional 53,245 shares in the last quarter. HighTower Advisors LLC boosted its holdings in Humana by 2.1% in the third quarter. HighTower Advisors LLC now owns 8,992 shares of the insurance provider’s stock worth $2,852,000 after acquiring an additional 187 shares in the last quarter. Finally, Concentric Capital Strategies LP bought a new position in Humana in the third quarter worth approximately $6,660,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Price Performance

Shares of HUM opened at $291.10 on Wednesday. The firm has a market cap of $35.05 billion, a PE ratio of 25.78, a P/E/G ratio of 2.31 and a beta of 0.53. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The firm has a fifty day simple moving average of $274.51 and a two-hundred day simple moving average of $328.34. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $502.73.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The firm had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. On average, equities analysts anticipate that Humana Inc. will post 15.86 EPS for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.22%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

Analyst Upgrades and Downgrades

HUM has been the topic of several recent research reports. Oppenheimer cut their price target on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a report on Thursday, October 3rd. Truist Financial lowered their price objective on Humana from $400.00 to $260.00 and set a “hold” rating for the company in a research note on Friday, October 11th. Wells Fargo & Company lowered their price objective on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research note on Monday, November 4th. UBS Group decreased their price target on Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, October 4th. Finally, Barclays raised their target price on Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 31st. Twenty research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.